The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing nine new Collaborative Research Centres (CRC) to further support ...

Congress 2025 took place in Berlin, Germany, a dynamic epicentre known for its blend of innovation, culture, and historical ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

We tend to overlook some bodily conditions and brush them off as nothing serious. However, a doctor’s visit may reveal a more ...

To help Class 9 students score high marks in the Annual Exam 2026, we have compiled complete CBSE Class 9 Study Material 2025 ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...

CUPERTINO, CALIFORNIA Apple today announced John Giannandrea, Apple's senior vice president for Machine Learning and AI Strategy, is stepping down ...

Eli Lilly and Company is rated Sell due to extreme dependence on GLP-1 drugs & valuation that assumes near-perfect conditions ...

DelveInsight's Mycosis Fungoides Market Insights report includes a comprehensive understanding of current treatment practices ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...